Product Program year 2025 Source: CMS Open Payments

Renal - Acute

Device Renal

Open in the dashboard

General payments

$1,532,392

2,298 payments

Research payments

$310,350

9 payments

Through program year 2025, $1,532,392 in general payments and $310,350 in research payments were reported against Renal - Acute (Renal).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

12 rows
Year Kind Amount Payments
2025 General $648,106 1,259
2025 Research $18,000 2
2024 General $434,600 711
2024 Research $25,192 1
2023 General $97,102 94
2022 General $31,195 57
2022 Research $32,315 1
2021 General $7,613 35
2021 Research $100,000 2
2020 General $86,694 61
2020 Research $134,843 3
2019 General $227,083 81

Breakdown

Who paid General payments · program years 2019–2025
  1. Baxter Healthcare $906,678 1,068 payments
  2. Vantive US Healthcare LLC $625,714 1,230 payments
Top recipients General payments · program year 2025
  1. Ram Subramanian Hepatology · Atlanta, GA $110,084 17% · 19 payments
  2. Javier Neyra Lozano Nephrology · Lexington, KY $35,513 6% · 32 payments
  3. University Of Alabama Hospital Teaching hospital · AL $33,000 5% · 2 payments
  4. Anjali Saxena Nephrology · San Jose, CA $30,411 5% · 37 payments
  5. Barbara McLean Atlanta, GA $26,646 4% · 76 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Nephrology Internal Medicine $209,965 38% · 138 practitioners
  2. Hepatology Internal Medicine $110,084 20% · 1 practitioner
  3. Critical Care Medicine Internal Medicine $53,590 10% · 20 practitioners
  4. Pediatric Nephrology Pediatrics $45,483 8% · 11 practitioners
  5. Pulmonary Disease Internal Medicine $32,298 6% · 8 practitioners

The top 5 of 35 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Georgia $170,139 27% · 15 recipients
  2. Ohio $82,561 13% · 18 recipients
  3. Alabama $52,591 8% · 17 recipients
  4. Kentucky $47,374 7% · 8 recipients
  5. California $46,178 7% · 11 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,298 general · 9 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record